Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Feeder-free mRNA reprogramming of urine-derived cells

ABSTRACT: Feeder-free mRNA reprogramming of urine-derived cells: combining a faithful reprogramming method with a readily accessible cell type

PROVIDER: PRJEB25626 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2407580.fastq.gz	Fastqsanger.gz
	ERR2407590.fastq.gz	Fastqsanger.gz
	ERR2407600.fastq.gz	Fastqsanger.gz
	ERR2407610.fastq.gz	Fastqsanger.gz
	ERR2407620.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 51

Similar Datasets

Optimized Approaches for Generation of Integration-free iPSCs from Human Urine-derived Cells with Small Molecules and Autologous Feeder

Project description:We generated iPSCs from human urine cells (hUCs) with the aid of small molecules and autologous hUC feeders. A compound cocktail including Cyclic Pifithrin-a, a p53 inhibitor and other compounds known for benefiting reprogramming like A-83-01, CHIR99021, Thiazovivin, NaB and PD0325901 was used to aid hUC reprogramming (Plan B). Aided by this cocktail, we achieved significantly improved efficiency (170 folds more) for hUC reprogramming and iPSC generation. In addition, to enable iPSC generation in some cases that massive cell death occurred during delivering reprogramming factors, we replaced Matrigel with autologous hUCs as feeder for reprogramming and iPSC generation (Plan C). Replacing Matrigel with autologous feeder not only enhanced reprograming, but also avoided concern using animal components for human iPSC generation. These were efficient approaches to enable iPSC generation from hUCs that were otherwise difficult for reprogramming, which would be valuable for banking patient’s specific iPSCs.

2017-02-10 | GSE79134 | GEO

Reprogramming of Human Urine Stem Cells into Cardiomyocytes via a Small Molecule Cocktail in Xeno-free conditions

Project description:Reprogramming autologous somatic cells into alternative lineages holds significant promise as a crucial cell source for regenerative therapy. Among various sources, human urine stem cells (hUSCs) have emerged as a highly promising candidate for reprogramming due to their ease of collection and high transdifferentiation potential. In this study, we present the first evidence for cardiac regeneration by directly converting hUSCs into functional cardiomyocytes under xeno-free conditions using a cocktail of 15 small molecules. This innovative protocol ensures a safe, animal-free reprogramming environment, enhancing its clinical applicability. The resulting chemically induced human cardiomyocyte-like cells (hCiCMs) exhibit several key characteristics of native cardiomyocytes, including the expression of cardiomyocyte-specific markers, display sarcomeric organization, and exhibit typical cardiac calcium flux and electrophysiological properties. Notably, transplantation of hCiCMs into the infarcted hearts of mice led to substantial improvements in cardiac function, characterized by enhanced contractility and reduced infarct size. Our findings validate the efficacy of the xeno-free differentiation protocol and highlight the potential of hUSC-derived hCiCMs as a viable and effective source for regenerative therapies in myocardial infarction. The use of hUSCs provides a readily accessible, autologous cell source, thereby paving the way for personalized and safer regenerative treatments for cardiac diseases.

2025-07-01 | GSE272220 | GEO

Bulk RNAseq anaysis of PSCs and differentiating cells under on-feeder and feeder-free cultures

Project description:Gene expression profiling of human iPSCs [201B7] under on-feeder, feeder-free [StemFit], and FGF inhibitor [100 nM PD173074] -treated cultures, and differentiating cells.

2022-03-09 | GSE195689 | GEO

A Chemically Defined Feeder-free System for the Establishment and Maintenance of the Human Naive Pluripotent State

Project description:The distinct states of pluripotency in the pre- and post-implantation embryo can be captured in vitro as naive and primed pluripotent stem cell cultures, respectively. The study and application of the naive state remains hampered, particularly in humans, partially due to current culture protocols relying on extraneous undefined factors such as feeders. Here we performed a small-molecule screen to identify compounds that facilitate chemically defined establishment and maintenance of human feeder-independent naive embryonic (FINE) stem cells. The expression profile in genic and repetitive elements of FINE cells resembles the 8-cell-to-morula stage in vivo, and only differs from feeder-dependent naive cells in genes involved in cell-cell/cell-matrix interactions. FINE cells offer several technical advantages, such as increased amenability to transfection and a longer period of genomic stability, compared with feeder-dependent cells. Thus, FINE cells will serve as an accessible and useful system for scientific and translational applications of naïve pluripotent stem cells.

2025-02-07 | GSE288982 | GEO

Mouse feeder-free alveolar organoids treated by bleomycin

Project description:To investigate the direct effect of bleomycin on alveolar epithelium, feeder-free mouse alveolar organoids were treated by bleomycin (100μM) for 48 hours in vitro and then analyzed.

2022-08-21 | GSE211531 | GEO

Human iPSCs derived under feeder free conditions displays an unqiue cell cycle and DNA replication genotype

Project description:Induced pluripotent stem cells (iPSCs) have been generated from various somatic cells under feeder-layer conditions. These feeder-derived iPSCs generated in different labs exhibit greater variability than between different traditional embryo derived hESC lines. For that reason, it is important to develop a standard and defined system for deriving autologous patient stem cells. We have generated iPSCs under feeder-free conditions using Matrigel coated vessels in chemically defined medium, mTeSR1. These feeder-free derived iPSCs are in many ways similar to feeder-derived iPSCs and also to hESCs, with respect to their pluripotent gene expression (OCT4, NANOG, SOX2), protein expression (OCT4, NANOG, SSEA4, TRA160) and differentiation capabilities. We conducted a whole genomic transcript analysis using Affymetrix Human Gene 1.0 ST arrays to elucidate the important differences between traditional feeder-derived iPSCs and feeder-free derived iPSCs. We reveal that feeder-free iPSCs have over-represented terms belonging to DNA replication and cell cycle genes which are lacking in feeder-derived iPSCs. Feeder-free iPSCs are in many aspects more similar to hESCs including; apoptosis, chromatin modification enzymes and mitochondrial energy metabolism. We have also identified potential biomarkers for fully reprogrammed iPSCs (FRZB) and partially reprogrammed iPSCs (POTEG, MX2) based on their expression trends across all cell types. In conclusion, feeder-free derived iPSCs is transcriptomically more similar to hESCs than feeder derived iPSCs, in many biological functions.

2011-06-03 | GSE21655 | GEO

Feeder-free directed differentiation of neural crest cells from human embryonic stem cells

Project description:Here we compare the transcriptional profile of neural crest cells differentiated on MS5 feeder cells (Lee et al., 2007 Nature Biotechnology) with neural crest cells differentiated in a feeder-free protocol. As controls, neuroepithelial cells (LSB) and wnt-induced neural crest cells were included.

2014-12-31 | GSE50643 | GEO

Urine Cell-Free RNA versus Plasma Cell-Free RNA for Monitoring of Immune and Urinary Tract Complications

Project description:While it is well known that cell-free RNA (cfRNA) can be isolated from urine, the diagnostic potential of this urine cfRNA, especially in comparison to plasma cfRNA, remains underexplored. Here, we directly compared the utility of urine cfRNA and plasma cfRNA for the monitoring of systemic and urinary tract related complications. We analyzed 272 matched plasma and urine cfRNA isolates obtained from three cohorts of patients: Hematopoietic Stem Cell Transplant (HSCT) recipients, patients with acute kidney injury (AKI), and healthy volunteers. The data highlight the unique cellular origins and properties of urinary and plasma RNA. Most importantly, we find that although plasma cfRNA is a superior analyte for monitoring immune and systemic complications, urinary cfRNA is more sensitive to complications of the urinary tract, including cell-type specific injury in the kidney. These findings highlight the potential of urine cfRNA as a novel analyte in diagnostic medicine.

2025-03-06 | GSE261018 | GEO

Bulk RNAseq anaysis of PSCs and differentiating cells under on-feeder and feeder-free cultures

Project description:Bulk RNAseq anaysis of PSCs and differentiating cells under on-feeder and feeder-free cultures

| PRJNA801842 | ENA

Human iPSCs derived under feeder free conditions displays an unqiue cell cycle and DNA replication genotype

2011-06-03 | E-GEOD-21655 | biostudies-arrayexpress